TrialRadiation oncology (London, England)2022

MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).

M Pavic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.